Multiple Sclerosis Pathology: Evolution of Pathogenetic Concepts

@article{Lassmann2005MultipleSP,
  title={Multiple Sclerosis Pathology: Evolution of Pathogenetic Concepts},
  author={Hans Lassmann},
  journal={Brain Pathology},
  year={2005},
  volume={15}
}
  • H. Lassmann
  • Published 1 July 2005
  • Medicine
  • Brain Pathology
This historical review describes the evolution of pathogenetic concepts of multiple sclerosis (MS) from the viewpoint of pathology. MS research is based on studies of descriptive neuropathology, performed during the 19th and early‐20th century, which defined the basic nature of the inflammatory demyelinating lesions. Advances in basic immunology and neurobiology, performed during the second half of the 20th century, paved the way for the understanding of the molecular mechanims involved in… 
View on Wiley
ncbi.nlm.nih.gov
125 Citations
Highly Influential Citations
2
Background Citations
42
Methods Citations
2
Results Citations
2

125 Citations

Citation Type

Citation Type

The molecular basis of neurodegeneration in multiple sclerosis
Toward biomarkers in multiple sclerosis: new advances
TLDR
In this review, the authors report recent advances in the field, focusing on the search of new antigens as a marker of the disease, in their relevance to the pathophysiology and diagnosis of the Disease.
Neuropathological Advances in Multiple Sclerosis
TLDR
It was already clear in the last years of the 1800s that MS is an inflammatory disease of the central nervous system with scattered areas of demyelination and relative sparing of axons.
Pathology of multiple sclerosis and related inflammatory demyelinating diseases.
Contribution of peptides to multiple sclerosis research.
TLDR
In the past decade, peptide-based research has been predominant in research aimed to identify and/or develop target antigens as synthetic probes for specific biomarkers as well as innovative immunomodulating therapies.
150th anniversary of clinical description of multiple sclerosis
TLDR
This essay commemorates the 150th anniversary of the publication of the pioneering work of Leopold Ordenstein and Jean-Martin Charcot by described the characteristic symptoms, predisposing age, and pathologic features of the disease, and emphasized the clear delineation from other chronic progressive disorders, especially paralysis agitans.
Pathoetiology of multiple sclerosis: are we barking up the wrong tree?
  • P. Stys
  • Medicine
    F1000prime reports
  • 2013
TLDR
It is equally likely that multiple sclerosis may be a degenerative disease that secondarily elicits an autoimmune response, and how this might influence therapeutic approaches is speculated.
Molecular Mechanisms of Oligodendrocyte Injury in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis
TLDR
Studying the molecular mechanisms of oligodendrocyte injury is likely to provide new perspective on the pathogenesis of MS and a rationale for cell protective therapies.
Altered astrocytic function in experimental neuroinflammation and multiple sclerosis
TLDR
This review will address the present knowledge that exists regarding the role of astrocytes in MS and experimental animal models of the disease, and suggest that disease progression and disability are better correlated with the maintenance of a persistent low‐grade inflammation inside the CNS, driven by local glial cells, like astroCytes and microglia.
Multiple sclerosis: an overview
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 79 REFERENCES
Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination
TLDR
At a given time point of the disease, the patterns of demyelination were heterogeneous between patients, but were homogenous within multiple active lesions from the same patient, suggesting that MS may be a disease with heterogeneous pathogenetic mechanisms.
Relapsing and remitting multiple sclerosis: Pathology of the newly forming lesion
TLDR
Clinical and pathological findings in 12 patients with relapsing and remitting multiple sclerosis, who died during or shortly after the onset of a relapse, raise the possibility of some novel process underlying new lesion formation in multiple sclerosis.
Pathogenesis of multiple sclerosis: The eyes only see what the mind is prepared to comprehend
  • B. Trapp
  • Medicine
    Annals of neurology
  • 2004
TLDR
The article questions current concepts of MS lesion pathogenesis by identifying pathological changes that precede leukocyte infiltration and demyelination by proposing apoptotic oligodendrocyte death in a circumscribed and relatively small area (2–10mm in diameter) as the initial event in new lesion formation.
A search for virus in multiple sclerosis.
  • D. Gilden
  • Medicine
    Hybridoma and hybridomics
  • 2002
TLDR
Current available molecular biologic strategies and techniques allow virus detection not possible 30 years ago, and could confirm Dr. Koprowski's prophetic vision and identify the virus that causes MS, including the mechanism by which demyelination is produced.
Prelude to the framing of a disease: multiple sclerosis in the period before Charcots Leçons.
  • J. Murray
  • Medicine
    International MS journal
  • 2004
TLDR
The early documentation of patients with what was probably MS and the contribution of physicians to the delineation of MS as a named disease are detailed.
Axonal damage in acute multiple sclerosis lesions.
TLDR
The results show the expression of amyloid precursor protein in damaged axons within acute multiple sclerosis lesions, and in the active borders of less acute lesions, which may have implications for the design and timing of therapeutic intervention.
The distribution of plaques in the cerebrum in multiple sclerosis
TLDR
The present study was undertaken to determine with some precision the position and relative frequency of plaques seen macroscopically in the cerebral hemispheres in a series of necropsied cases of multiple sclerosis.
Axonal transection in the lesions of multiple sclerosis.
TLDR
Transected axons are common in the lesions of multiple sclerosis, and axonal transection may be the pathologic correlate of the irreversible neurologic impairment in this disease.
Neuropathology of Multiple Sclerosis
Multiple sclerosis (MS) is a disease with no indication for neurosurgical intervention. If, nevertheless, it has become the subject of this Neurosurgical Congress as “misdiagnosis”, this is probably…
Multiple sclerosis: remyelination of nascent lesions.
TLDR
The study provides new evidence that both oligodendrocytes and myelin are destroyed in new lesions, that this activity ceases completely in many lesions within a few weeks, and that remyelination frequently ensues following repopulation of the plaque by oligod endodermictes.
...
1
2
3
4
5
...